Skip to main content
Log in

Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Maloney DG, Grillo-Lopez AJ, White CA, Bodkin DJ, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R . IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma Blood 1997 90: 2188–2195

    CAS  PubMed  Google Scholar 

  2. Maloney DG, Grillo-Lopez AJ, Bodkin DJ, White CA, Liles T-M, Royston I, Varns C, Rosemberg J, Levy R . IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed low-grade non-Hodgkin's lymphoma J Clin Oncol 1997 16: 3266–3274

    Article  Google Scholar 

  3. McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK . Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J Clin Oncol 1998 16: 2825–2833

    Article  CAS  PubMed  Google Scholar 

  4. Feuring-Buske M, Buske C, Unterhalt M, Hiddemann W . Recent advances in antigen-targeted therapy in non-Hodgkin's lymphoma Ann Hematol 2000 79: 167–174

    Article  CAS  PubMed  Google Scholar 

  5. Hainsworth JD, Burris III HA, Morrisey LH, Litchy S, Scullin DC Jr, Bearden JD III, Richards P, Greco FA . Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin's lymphoma Blood 2000 95: 3052–3056

    CAS  PubMed  Google Scholar 

  6. Winkler U, Jensen M, Manzke O, Shultz H, Diehl V, Engert A . Cytokine-release syndrome in patients with B cell chronic lymphocytic leukemia and high lymphocitic counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8) Blood 1999 94: 2217–2224

    CAS  PubMed  Google Scholar 

  7. Byrd JC, Waselenko JK, Maneatis TJ, Murphy T, Ward FT, Monahan BR, Sipe MA, Donegan S, White CA . Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance J Clin Oncol 1999 17: 791–795

    Article  CAS  PubMed  Google Scholar 

  8. Lim LC, Koh LP, Tan P . Fatal cytokine release syndrome with chimeric anti-CD20 monoclonal antibody rituximab in a 71-year-old patient with lymphocytic leukemia J Clin Oncol 1999 17: 1962–1963

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rigamonti, C., Volta, C., Colombi, S. et al. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion. Leukemia 15, 186–187 (2001). https://doi.org/10.1038/sj.leu.2401987

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401987

  • Springer Nature Limited

This article is cited by

Navigation